Open tender · Germany · Pharmaceutical products
Open house Arzneimittelrabattverträge Ranibizumab in der Darreichungsform Injektionslösung in der Durchstechflasche, ATC S01LA04
In EnglishOpen house drug discount agreements for Ranibizumab in injection solution in vials, ATC S01LA04
AOK Bayern - Die Gesundheitskasse
AOK Bayern - Die Gesundheitskasse in Germany is inviting bids for “Open house drug discount agreements for Ranibizumab in injection solution in vials, ATC S01LA04”. Bids close on 5 March 2027, 12:00 CET. askTender lists every requirement to qualify and checks whether your company meets them.
The work
Non-exclusive discount agreements for Ranibizumab injection solution in single-dose vial.
Key facts
- Procedure
- Contract notice
Before you bid, askTender
Everything else is in your askTender account
askTender has broken this tender down into 0 requirements to qualify and the 3 documents a bidder must file.
- What it takes to qualify: every requirement, in the tender’s own words
- Whether your company qualifies: your profile checked against each requirement, showing what you have, what’s missing and how to close the gap
- The documents to file: a checklist, with draft declarations ready to sign
- A bid partner for any requirement you can’t meet alone
- The tender documents, ready to open
- Alerts for new tenders like this one
Public data: TED – Tenders Electronic Daily. © European Union, 1998–2026. Notices reused under Commission Decision 2011/833/EU. · Sources & licences